Wealthy countries including U.S., Britain, EU and Japan have secured more than 1 billion doses of yet to be approved Coronavirus vaccines, raising worries that the rest of the world will be at the back of the queue in the global effort to defeat the pathogen.
Moves by the U.S. and U.K. to secure
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
